home / stock / igxt / igxt news


IGXT News and Press, Intelgenx Techs Corp From 03/21/24

Stock Information

Company Name: Intelgenx Techs Corp
Stock Symbol: IGXT
Market: OTC
Website: intelgenx.com

Menu

IGXT IGXT Quote IGXT Short IGXT News IGXT Articles IGXT Message Board
Get IGXT Alerts

News, Short Squeeze, Breakout and More Instantly...

IGXT - IntelGenx GAAP EPS of -$0.01, revenue of $0.43M

2024-03-21 07:49:22 ET More on IntelGenx Seeking Alpha’s Quant Rating on IntelGenx Financial information for IntelGenx Read the full article on Seeking Alpha For further details see: IntelGenx GAAP EPS of -$0.01, revenue of $0.43M

IGXT - IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results

SAINT LAURENT, Quebec, March 21, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the three- and twelve-month periods ended December 31, 2023. All dollar amounts are expressed in U.S. currency...

IGXT - Expected US Company Earnings on Thursday, March 21st, 2024

X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...

IGXT - IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 - Conference Call to Follow

SAINT LAURENT, Quebec, March 14, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its fourth quarter and full year 2023 financial results before market open on Thursday,...

IGXT - IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences

SAINT LAURENT, Quebec, March 11, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “ Company ”) announces that its wholly-owned subsidiary, IntelGenx Corp. (“ IntelGenx Corp. ”), has entered into a third amended and restated loan...

IGXT - UPDATE -- IntelGenx Launches Preferred Share Regulation A Offering

SAINT LAURENT, Quebec, Feb. 20, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced the launch of a Regulation A offering of up to 2,000,000 shares of Series A Convertible Cumulative Preferred Stock (“Series A Preferred Stockȁ...

IGXT - IntelGenx Launches Preferred Share Regulation A Offering

SAINT LAURENT, Quebec, Feb. 20, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced the launch of a Regulation A offering of up to 2,000,000 shares of Series A Convertible Cumulative Preferred Stock (“Series A Preferred Stockȁ...

IGXT - Studies Validate Advantages of Administering Drugs to Pets via IntelGenx's VetaFilm® Platform

SAINT LAURENT, Quebec, Feb. 05, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced positive results from a proof-of-concept (“POC”) study to assess the palatability, owner-perceived acceptability, and ease of repeated ...

IGXT - IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm®

SAINT LAURENT, Quebec, Dec. 18, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has entered into development and license agreements (collectively the “Agreements”) with a wholly-owned subsidiary of Covenant ...

IGXT - IntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000

SAINT LAURENT, Quebec, Dec. 05, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“ IntelGenx ” or the “ Company ”) announces the closing of the previously announced subsequent non-brokered private placement (the “ Subsequen...

Previous 10 Next 10